Results
|
1.
|
|
|
2.
|
Risk factors differ between recurrent and incident preeclampsia: a hospital-based cohort study. MedStar authors:
Citation: - Annals of Epidemiology. 24(12):871-7e3, 2014 Dec.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology, Maternal-Fetal Medicine
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Albert PS, Boghossian NS, Hinkle SN, Laughon SK, Mendola P, Yeung E, Zhang C
|
|
3.
|
Rates of recurrent preterm birth by maternal body habitus in women receiving 17alpha-hydroxyprogesterone caproate. MedStar authors:
- Boyle, Annelee
- Driggers, Rita W
- Feghali, Maisa N
- Timofeev, Julia
Year: 2013
Citation: - Journal of Maternal-Fetal & Neonatal Medicine. 26(9):881-4, 2013 Jun.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Maternal-Fetal Medicine
Medline publication type:
All authors: - Boyle A, Driggers RW, Feghali M, Istwan N, Rhea D, Timofeev J
|
|
4.
|
|
|
5.
|
Obstetric and Neonatal Risks Among Obese Women Without Chronic Disease. MedStar authors:
Year: 2016
Citation: - Obstetrics & Gynecology. 128(1):104-12, 2016 Jul
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Maternal-Fetal MedicineIN - Kim, Sung Soo. Epidemiology Branch and the Biostatistics and Bioinformatics Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland.
Medline publication type:
All authors: - Chen Z, Epps NM, Grantz KL, Hinkle SN, Kim SS, Mendola P, Smarr MM, Wallace ME, Zhu Y
|
|
6.
|
Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study. MedStar authors:
Year: 2011
Citation: - Diabetes Care. 34(10):2306-13, 2011 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Best LG, Calhoun D, Dixon AE, Lee ET, Marion S, Rhoades ER, Schaefer C, Yeh F, Zhang Y
|
|
7.
|
Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
- Zhu, Jianhui
Year: 2012
Citation: - Diabetes Care. 35(4):840-7, 2012 Apr.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Devereux RB, Howard BV, Kizer JR, Lee ET, Umans JG, Wolfert RL, Zhu J
|
|
8.
|
Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?. MedStar authors:
- Mete, Mihriye
- Zeymo, Alexander
Year: 2020
Citation: - Journal of Diabetes & its Complications. 34(4):107513, 2020 04.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Anhalt H, Flokas ME, Gourgari E, Mete M, Rother KI, Zeymo A
|
|
9.
|
Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). MedStar authors:
Year: 2017
Citation: - Diabetic Medicine. 34(12):1747-1755, 2017 Dec.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Knowler WC, Mather KJ, Pan Q, Perreault L, The Diabetes Prevention Program Research Group
|
|
10.
|
|
|
11.
|
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. MedStar authors:
Year: 2021
Citation: - Cancer. 127(4):598-608, 2021 02 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Banack HR, Barac A, Beebe-Dimmer JL, Caan BJ, Chlebowski RT, Foraker R, Hastert TA, Hovsepyan G, Liu S, Luo J, Manson JE, Neuhouser ML, Okwuosa TM, Pan K, Qi L, Ruterbusch JJ, Shadyab AH, Simon MS, Thomson CA, Wactawski-Wende J, Waheed N
|
|
12.
|
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
|